- Home
- TTSH vs ALDX Comparison
TTSH vs ALDX Comparison
Compare TTSH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTSH
- ALDX
- Stock Information
- Founded
- TTSH 1985
- ALDX 2004
- Country
- TTSH United States
- ALDX United States
- Employees
- TTSH N/A
- ALDX N/A
- Industry
- TTSH Blank Checks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- TTSH Finance
- ALDX Health Care
- Exchange
- TTSH Nasdaq
- ALDX Nasdaq
- Market Cap
- TTSH 279.3M
- ALDX 296.0M
- IPO Year
- TTSH N/A
- ALDX 2014
- Fundamental
- Price
- TTSH $6.34
- ALDX $5.08
- Analyst Decision
- TTSH
- ALDX Strong Buy
- Analyst Count
- TTSH 0
- ALDX 2
- Target Price
- TTSH N/A
- ALDX $9.50
- AVG Volume (30 Days)
- TTSH 136.0K
- ALDX 670.9K
- Earning Date
- TTSH 11-04-2025
- ALDX 11-05-2025
- Dividend Yield
- TTSH N/A
- ALDX N/A
- EPS Growth
- TTSH N/A
- ALDX N/A
- EPS
- TTSH N/A
- ALDX N/A
- Revenue
- TTSH $338,787,000.00
- ALDX N/A
- Revenue This Year
- TTSH N/A
- ALDX N/A
- Revenue Next Year
- TTSH N/A
- ALDX $63.48
- P/E Ratio
- TTSH N/A
- ALDX N/A
- Revenue Growth
- TTSH N/A
- ALDX N/A
- 52 Week Low
- TTSH $4.62
- ALDX $1.14
- 52 Week High
- TTSH $7.75
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- TTSH 53.71
- ALDX 50.98
- Support Level
- TTSH $6.28
- ALDX $4.70
- Resistance Level
- TTSH $6.40
- ALDX $5.35
- Average True Range (ATR)
- TTSH 0.09
- ALDX 0.26
- MACD
- TTSH 0.00
- ALDX 0.01
- Stochastic Oscillator
- TTSH 66.67
- ALDX 69.70
About TTSH Tile Shop Holdings Inc.
Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.